de Tute R - Search Results

1

The clinical impact of staging bone marrow examination on treatment decisions and prognostic assessment of lymphoma patients.

Painter D, Smith A, de Tute R, Crouch S, Roman E, Jack A. Painter D, et al. Among authors: de tute r. Br J Haematol. 2015 Jul;170(2):175-8. doi: 10.1111/bjh.13412. Epub 2015 Apr 29. Br J Haematol. 2015. PMID: 25920510 Free article.

2

Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens.

Rawstron AC, de Tute R, Jack AS, Hillmen P. Rawstron AC, et al. Among authors: de tute r. Leukemia. 2006 Dec;20(12):2102-10. doi: 10.1038/sj.leu.2404416. Epub 2006 Oct 19. Leukemia. 2006. PMID: 17051247

3

B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle.

Bennett F, Rawstron A, Plummer M, de Tute R, Moreton P, Jack A, Hillmen P. Bennett F, et al. Among authors: de tute r. Br J Haematol. 2007 Nov;139(4):600-4. doi: 10.1111/j.1365-2141.2007.06790.x. Br J Haematol. 2007. PMID: 17979945 Free article.

4

Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

Rawstron AC, Bennett FL, O'Connor SJ, Kwok M, Fenton JA, Plummer M, de Tute R, Owen RG, Richards SJ, Jack AS, Hillmen P. Rawstron AC, et al. Among authors: de tute r. N Engl J Med. 2008 Aug 7;359(6):575-83. doi: 10.1056/NEJMoa075290. N Engl J Med. 2008. PMID: 18687638 Free article.

5

Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.

Rawstron AC, Shingles J, de Tute R, Bennett F, Jack AS, Hillmen P. Rawstron AC, et al. Among authors: de tute r. Cytometry B Clin Cytom. 2010;78 Suppl 1:S42-6. doi: 10.1002/cyto.b.20534. Cytometry B Clin Cytom. 2010. PMID: 20839337 Free article.

6

Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse.

Cohen OC, Counsell N, Rabin N, Popat R, Owen RG, Popova B, Schofield O, Clifton-Hadley L, Lyons-Lewis J, Rawstron A, Spence C, de Tute RM, Hughes D, Moore S, Smith P, Yong KL. Cohen OC, et al. Among authors: de tute rm. Br J Haematol. 2019 Jun;185(5):948-951. doi: 10.1111/bjh.15649. Epub 2018 Nov 20. Br J Haematol. 2019. PMID: 30460696 Free article. No abstract available.

7

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort.

Lamb MJ, Smith A, Painter D, Kane E, Bagguley T, Newton R, Howell D, Cook G, de Tute R, Rawstron A, Patmore R, Roman E. Lamb MJ, et al. Among authors: de tute r. BMJ Open. 2021 Feb 22;11(2):e041296. doi: 10.1136/bmjopen-2020-041296. BMJ Open. 2021. PMID: 33619185 Free PMC article.

8

Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network.

Lamb M, Painter D, Howell D, Barrans S, Cargo C, de Tute R, Tooze R, Burton C, Patmore R, Roman E, Smith A. Lamb M, et al. Among authors: de tute r. Cancer Epidemiol. 2024 Feb;88:102513. doi: 10.1016/j.canep.2023.102513. Epub 2023 Dec 30. Cancer Epidemiol. 2024. PMID: 38160571 Free article.

9

A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma.

de Tute RM, Jack AS, Child JA, Morgan GJ, Owen RG, Rawstron AC. de Tute RM, et al. Leukemia. 2007 Sep;21(9):2046-9. doi: 10.1038/sj.leu.2404815. Epub 2007 Jul 26. Leukemia. 2007. PMID: 17657223 No abstract available.

10

Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma.

Polson AG, Williams M, Gray AM, Fuji RN, Poon KA, McBride J, Raab H, Januario T, Go M, Lau J, Yu SF, Du C, Fuh F, Tan C, Wu Y, Liang WC, Prabhu S, Stephan JP, Hongo JA, Dere RC, Deng R, Cullen M, de Tute R, Bennett F, Rawstron A, Jack A, Ebens A. Polson AG, et al. Among authors: de tute r. Leukemia. 2010 Sep;24(9):1566-73. doi: 10.1038/leu.2010.141. Epub 2010 Jul 1. Leukemia. 2010. PMID: 20596033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters